Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

The Kids researchers awarded Raine Medical Research Foundation funding

Congratulations to three The Kids Research Institute Australia researchers, who have been awarded funding from the Raine Medical Research Foundation.

Congratulations to three The Kids Research Institute Australia researchers, who have been awarded funding from the Raine Medical Research Foundation.

Dr Melissa O'Donnell, Dr Ashleigh Lin and Dr Laurence Cheung were all awarded grants to continue research that improves the lives of children. 

Director of The Kids Research Institute Australia Professor Jonathan Carapetis congratulated them on their funding success.

"These grants will enable Melissa, Ashleigh and Laurence to continue investigating alcohol related harm, gender identity and leukaemia respectively," Professor Carapetis said.

"They are each examples of the high calibre of research talent that we have here at the Institute and it is fantastic to see our staff recognised yet again for the positive impact they are making to child health."

Grant details:

Dr Melissa O'Donnell was awarded a Raine Priming Grant supported by the Jon and Caro Stewart Family Foundation for her project entitled Alcohol-related harm in young people:  developing a longitudinal evidence base, and named theStewart/BrightSpark/Raine Project as it was ranked "outstanding" in the area of child health research. Dr O'Donnell received funding of $187,128

Dr Ashleigh Lin received $150,000  in funding for her project: GENTLE: The GENder identiTy Longitudinal Experience Project.

Dr Ashleigh Lin also received the 2017 Strachan Memorial Prize for her publication: Outcomes of non-transitioned cases in a sample at ultra-high risk for psychosis: a medium to long-term follow-up study, published in The American Journal of Psychiatry. Dr Lin will receive a $5,000 travel grant.

Dr Laurence Cheung was awarded a 2017 BrightSpark Research Collaboration Award for his project: Identification of novel drug combinations to cure high-risk infant leukaemia, and received $8,988.